Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 41 results for "diovan hct"

Valsartan Market (CAS 137862-53-4) 2020 Forecasts and Patent Search, Valsartan Patent Extension and Data Exclusivity Expiry Snapshot for 51 Countries in New Research Reports

July 1, 2015July 1, 2015

/PRNewswire/ — offers 2015 Valsartan (CAS 137862-53-4) Industry Report Global and Chinese Market Scenario, Valsartan Comprehensive patent search and Valsartan Patent, Extension and Data Exclusivity Expiry Snapshot (51 ..., 1 day ago

Radiant Insights: Antihypertensive Therapeutics Market Trends, Growth and Forecast up to 2020

GBI Research, the leading business intelligence provider, has released its latest research, "Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries", ...
 Bloomberg1 month ago Antihypertensive Therapeutics Market Trends, Growth and Forecast up to 2020  Individual.com1 month ago

Packaging & Bottling - Stick with it

Designs on you: Effective package design is proven to deliver tangible results and adherence gains, translating into improved health outcomes for patients With recent governmental reforms in healthcare across the US, Europe, and extending into ...
 European Pharmaceutical Manufacturer1 month ago

Big Pharma's cardiovascular sales ain't what they used to be

Slumping sales for cardiovascular drugs isn't exactly a new phenomenon for Big Pharma, with some of the industry's top drugmakers suffering from recent patent expirations. But a new report shows which CV franchises have been hurt the most. ...
 FiercePharma1 month ago

100 Best-Selling, Most Prescribed Branded Drugs Through March

The hypothyroid drug levothyroxine ( Synthroid , AbbVie) was the most prescribed drug in the United States, and the arthritis drug adalimumab ( Humira , Abbott Laboratories) was the best-selling drug through March of this year, according to recent ...
 Dermatology Online Journal1 month ago

CMS spent $103 billion on Medicare Part D in 2013, $2.5 billion on Nexium

CMS spent $2.5 billion on the heartburn drug in 2013 on 8.2 million claims. Henry Powderly, Managing Editor The Center for Medicare and Medicaid Services spent more than $103 billion on prescription drugs in 2013 under the Medicare Part D ...
 Healthcare Finance News2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less